Effects of Alcohol Consumption on Atrial Fibrillation Episodes
Official title: Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation (FULL-PROOF)
Run by University of California, San Francisco · NCT06754176 · Data updated 2026-11-12
This study is testing whether drinking small to moderate amounts of alcohol affects how often people with paroxysmal atrial fibrillation have episodes of irregular heartbeats.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 2 sites (San Francisco, California and 1 other locations) |
| Status | Recruiting |
| Started | April 17, 2025 |
| Main results expected | December 2026 |
| Study ends | August 2029 |
| Registry record updated | December 23, 2025 |
| Trial ID | NCT06754176 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with paroxysmal AFib who consume alcohol at least once a week and are comfortable using a smartphone.
✕Probably not a fit
Patients with a history of alcohol addiction, liver disease, or those currently pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the short-term effects of minimal and moderate alcohol consumption on episodes of paroxysmal atrial fibrillation (AFib) in participants. Using a case-crossover randomized design, participants will be assigned daily to either avoid or consume alcohol over a 14-day monitoring period. They will wear various monitoring devices, including an ECG monitor and an alcohol monitor, while completing daily surveys to assess their alcohol intake and heart rhythm. The goal is to determine if allowing alcohol consumption increases the occurrence of AFib episodes.
Why it matters
Potential benefit: If successful, this study could provide insights into safe alcohol consumption levels for patients with paroxysmal AFib.
How similar studies have gone: While there have been studies on alcohol and AFib, this specific randomized approach to assess real-time effects is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Comfortable reading and writing in English * Have a smartphone and willing and able to use the Eureka mobile application * Currently diagnosed with paroxysmal AFib without a plan to change their AFib management during the two-week monitoring period * At least one episode of AFib in the past month OR, in the judgement of a healthcare provider, could potentially have one episode of AF in the next month * Drank alcohol at least 1 day/week on average in the past month * Willing and able to be randomly assigned daily to avoid or not avoid drinking alcohol over a 2-week period * Willing and able to provide written informed consent Exclusion Criteria * Only post-operative AFib * Greater than 40% ventricular pacing * History of alcohol addiction or abuse determined by self-reported history or AUDIT-C score * Intolerance to alcohol * History of liver disease * Currently incarcerated * Currently pregnant or trying to get pregnant
Where it's running
-
UCSF Medical Center at Parnassus
San Francisco, California, United States Recruiting -
UCSF Medical Center at Mission Bay
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Gregory Marcus, MD, MAS — University of California, San Francisco
- Study coordinator: Gregory M Marcus, MD, MAS
- Email: greg.marcus@ucsf.edu
- Phone: 415-476-5706
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Progressive Resistance Training First to Help AF and HFpEF Patients Feel Better
This trial tests whether starting with progressive resistance training before aerobic exercise can improve exercise capacity and quality of life in people aged 60 and older who have atrial fibrillation and HFpEF.
-
Digital MediYoga for quality of life and heart measures in paroxysmal atrial fibrillation
This trial will test whether a 12-week, app-delivered MediYoga program can improve disease-specific quality of life and reduce blood pressure and heart rate in adults with paroxysmal atrial fibrillation.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.